Cargando…

Intestinal Colonization by Candida albicans Alters Inflammatory Responses in Bruton's Tyrosine Kinase-Deficient Mice

The commensal yeast Candida albicans is part of the human intestinal microflora and is considered a “pathobiont”, a resident microbe with pathogenic potential yet harmless under normal conditions. The aim of this study was to investigate the effect of C. albicans on inflammation of the intestinal tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strijbis, Karin, Yilmaz, Ömer H., Dougan, Stephanie K., Esteban, Alexandre, Gröne, Andrea, Kumamoto, Carol A., Ploegh, Hidde L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224491/ https://www.ncbi.nlm.nih.gov/pubmed/25379804 http://dx.doi.org/10.1371/journal.pone.0112472

Ejemplares similares

Bruton's Tyrosine Kinase (BTK) and Vav1 Contribute to Dectin1-Dependent Phagocytosis of Candida albicans in Macrophages
por: Strijbis, Karin, et al.
Publicado: (2013)

Disruption of Sphingolipid Biosynthesis Blocks Phagocytosis of Candida albicans
por: Tafesse, Fikadu G., et al.
Publicado: (2015)

Interplay between host and Candida albicans during commensal gut colonization
por: Day, Andrew W., et al.
Publicado: (2023)

Variation in Candida albicans EFG1 Expression Enables Host-Dependent Changes in Colonizing Fungal Populations
por: Pierce, Jessica V., et al.
Publicado: (2012)

Protein Ligation in Living Cells Using Sortase
por: Strijbis, Karin, et al.
Publicado: (2012)

Self-Regulation of Candida albicans Population Size during GI Colonization
por: White, Sarah Jane, et al.
Publicado: (2007)

Manipulation of Host Diet To Reduce Gastrointestinal Colonization by the Opportunistic Pathogen Candida albicans
por: Gunsalus, Kearney T. W., et al.
Publicado: (2015)

Bruton's tyrosine kinase: oncotarget in myeloma
por: Tai, Yu-Tzu, et al.
Publicado: (2012)

Editorial: Targeting Bruton Tyrosine Kinase
por: Brunner, Cornelia, et al.
Publicado: (2022)

Targeting Bruton’s Tyrosine Kinase in CLL
por: Ahn, Inhye E., et al.
Publicado: (2021)

Regulatory Phosphorylation of Ikaros by Bruton's Tyrosine Kinase
por: Ma, Hong, et al.
Publicado: (2013)

Second-generation inhibitors of Bruton tyrosine kinase
por: Wu, Jingjing, et al.
Publicado: (2016)

Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma
por: Von Suskil, Max, et al.
Publicado: (2021)

Bruton’s Tyrosine Kinase and Its Isoforms in Cancer
por: Wang, Xianhui, et al.
Publicado: (2021)

Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis
por: Schneider, Raphael, et al.
Publicado: (2022)

Bruton tyrosine kinase inhibitors for multiple sclerosis
por: Krämer, Julia, et al.
Publicado: (2023)

Decreased Ecological Resistance of the Gut Microbiota in Response to Clindamycin Challenge in Mice Colonized with the Fungus Candida albicans
por: Markey, Laura, et al.
Publicado: (2021)

The game theory of Candida albicans colonization dynamics reveals host status-responsive gene expression
por: Tyc, Katarzyna M., et al.
Publicado: (2016)

Inhibition of Bruton's Tyrosine Kinase Protects Against Burn Sepsis-Induced Intestinal Injury
por: Wan, Jia, et al.
Publicado: (2022)

Functional Importance of the DNA Binding Activity of Candida albicans Czf1p
por: Petrovska, Ivana, et al.
Publicado: (2012)

Extracellular enolase of Candida albicans is involved in colonization of mammalian intestinal epithelium
por: Silva, Richard C., et al.
Publicado: (2014)

From intestinal colonization to systemic infections: Candida albicans translocation and dissemination
por: Sprague, Jakob L., et al.
Publicado: (2022)

Role of Bruton's Tyrosine Kinase in B Cell Development
por: Maas, Alex, et al.
Publicado: (2001)

Novel Bruton’s tyrosine kinase inhibitors currently in development
por: D’Cruz, Osmond J, et al.
Publicado: (2013)

Role of Bruton’s tyrosine kinase in B cells and malignancies
por: Pal Singh, Simar, et al.
Publicado: (2018)

Bruton’s Tyrosine Kinase Inhibition Promotes Myelin Repair
por: Martin, Elodie, et al.
Publicado: (2020)

Bruton’s Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
por: Arneson, Laura C, et al.
Publicado: (2021)

Targeting Bruton’s Tyrosine Kinase in Inflammatory and Autoimmune Pathologies
por: Neys, Stefan F. H., et al.
Publicado: (2021)

Editorial: New Insights on Bruton’s Tyrosine Kinase Inhibitors
por: Smith, C. I. Edvard, et al.
Publicado: (2021)

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
por: Khan, Abdullah Mohammad
Publicado: (2022)

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
por: Ababneh, Obada, et al.
Publicado: (2022)

Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemia
por: Castillo, Jorge J., et al.
Publicado: (2023)

Bruton’s tyrosine kinase inhibitors in the treatment of multiple sclerosis
por: Shulga, Olga, et al.
Publicado: (2023)

Calmodulin Binding to Dfi1p Promotes Invasiveness of Candida albicans
por: Davis, Talya R., et al.
Publicado: (2013)

Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014)

Bypass of Dfi1 Regulation of Candida albicans Invasive Filamentation by Iron Limitation
por: Junier, Ashlee, et al.
Publicado: (2022)

Bruton's Tyrosine Kinase Is Essential for Human B Cell Tolerance
por: Ng, Yen-Shing, et al.
Publicado: (2004)

Bruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity
por: Weber, Alexander N. R., et al.
Publicado: (2017)

Role of Bruton’s Tyrosine Kinase in Stage III Colorectal Cancer
por: Basile, Debora, et al.
Publicado: (2019)

Structural mechanism for Bruton’s tyrosine kinase activation at the cell membrane
por: Wang, Qi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uj4oveq19tvpp8tb12p1q90fn1